SEC Form 4 · accession 0001078782-15-000331
AXIM BIOTECHNOLOGIES, INC. · AXIM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George Anastassov
Officer — President · Director · 10% Owner
Period of report
Feb 23, 2015
Accepted (ET)
Mar 3, 2015 · 4:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001514946
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 23, 2015 | A | 2,000 | $0.00 | A | 14,945,650 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reporting person holds 2,000 shares Directly and 14,943,650 shares Indirectly held by Sanammad Foundation.